Ceftiofur is a semisynthetic broad-spectrum cephalosporin antibiotic, which acts against bacterial activity.
Ceftiofur is used as veterinary medicine for the treatment of respiratory disorders in beef or dairy cattle and pigs.

The global Ceftiofur market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ceftiofur volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ceftiofur market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ceftiofur in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ceftiofur manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Novartis
Cadila Pharmaceuticals
AN PharmaTech
Norbrook Laboratories
Bayer
Zoetis
Cephazone Pharma
Ceva Sant Animale
HIPRA

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
By type
Ceftiofur Sodium
Ceftiofur Hydrochloride
Others
By animal type
Cattle
Horse
Swine
Sheep
Others

Segment by Application
Respiratory Infections
Urinary Tract Infections
Bovine Interdigital Necrobacillosis
Others